Baird Medical Investment Holdings Ltd
- Close
- Jun 30, 2026
- Market cap
- —
- no share count on file
- Filings
- 83
FY 2025−39.2% FY25 yoy
FY 2025N/M FY25 yoy
FY 2025N/M FY25 yoy
FY 2025derivedN/M FY25 yoy
FY 2025N/M FY25 yoy
FY 2025−94.0% FY25 yoy
Price
Jun 30, 2026 · 13F quarter end
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $22,537,016 | reported | |
| FY 2024 | 2024-12-31 | $37,037,108 | reported | |
| FY 2023 | 2023-12-31 | $31,457,908 | reported | |
| FY 2022 | 2022-12-31 | $35,091,174 | reported |
Segments
LineFY2025ShareChange
PRC$13.50M60%−62.7%
Hong Kong$7.99M35%—
United States$938.75K4.2%+10.2%
MALAYSIA$106.00K0.5%—
NEPAL$8.48K0.0%—
Total$22.54M
Surgical & medical instruments & apparatus
Baird Medical Investment Holdings Ltd is the 77th largest of the 144 covered companies the SEC files under this code, by revenue. SIC 3841
CompanyRevenueGrowthNet marginMarket cap
SRTSSensus Healthcare, Inc.$27.5M34.3%28.1%$52.7M
BDMDWBaird Medical Investment Holdings Ltd (this company)$22.5M39.2%121.0%$4.3M
DRIODarioHealth Corp.$22.4M17.3%186.6%$41.2MMDAISpectral AI, Inc.$19.7M33.6%38.5%$43.6MSNOASonoma Pharmaceuticals, Inc.$19.5M36.7%16.3%$6.3MNEPHNephros Inc$18.8M32.7%6.4%$35.5MVVOSVivos Therapeutics, Inc.$17.4M16.0%121.4%$1.9MPROFProfound Medical Corp.$16.1M65.3%264.4%$270.7MBTCYBiotricity Inc.$16.0M16.0%15.0%$995.7KPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Baird Medical Investment Holdings Ltd · CIK 1982444 · Engraved from SEC EDGAR